TCL Archive DCPC Board Agrees to Commit $62 Million To Trials Of Prostate, Lung, Colorectal Cancer Screening October 20, 1989
TCL Archive Drug Development: ODAC Discussion May Offer Clues For Sponsors of Cytostatic Drugs June 16, 1999
TCL Archive In Brief: VP-16 NDA Approved By FDA Only For Refractory Testicular Cancer; Removed From Group C List December 2, 1983
